224 related articles for article (PubMed ID: 32161031)
21. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease.
Scherfler C; Seppi K; Mair KJ; Donnemiller E; Virgolini I; Wenning GK; Poewe W
Brain; 2012 Nov; 135(Pt 11):3348-54. PubMed ID: 23043142
[TBL] [Abstract][Full Text] [Related]
22. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
[TBL] [Abstract][Full Text] [Related]
23. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
[TBL] [Abstract][Full Text] [Related]
24. Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features.
Iranzo A
Curr Neurol Neurosci Rep; 2013 Sep; 13(9):373. PubMed ID: 23881622
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
26. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
27. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
[TBL] [Abstract][Full Text] [Related]
28. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
Liu R; Umbach DM; Tröster AI; Huang X; Chen H
Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
[TBL] [Abstract][Full Text] [Related]
29. VMAT2 availability in Parkinson's disease with probable REM sleep behaviour disorder.
Valli M; Cho SS; Uribe C; Masellis M; Chen R; Mihaescu A; Strafella AP
Mol Brain; 2021 Nov; 14(1):165. PubMed ID: 34758845
[TBL] [Abstract][Full Text] [Related]
30. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
[TBL] [Abstract][Full Text] [Related]
31. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
[TBL] [Abstract][Full Text] [Related]
32. REM sleep behavior disorder in early Parkinson's disease predicts the rapid dopaminergic denervation.
Kim YE; Kim YJ; Hwang HS; Ma HI
Parkinsonism Relat Disord; 2020 Nov; 80():120-126. PubMed ID: 32987358
[TBL] [Abstract][Full Text] [Related]
33. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
[TBL] [Abstract][Full Text] [Related]
35. Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control.
Shin HY; Joo EY; Kim ST; Dhong HJ; Cho JW
Neurol Sci; 2013 Jun; 34(6):935-40. PubMed ID: 22843227
[TBL] [Abstract][Full Text] [Related]
36. Symmetric and Profound Monoaminergic Degeneration in Parkinson's Disease with Premotor REM Sleep Behavior Disorder.
Woo KA; Kim HJ; Shin JH; Cho K; Choi H; Jeon B
J Parkinsons Dis; 2024; 14(4):823-831. PubMed ID: 38640171
[TBL] [Abstract][Full Text] [Related]
37. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder.
Chahine LM; Brumm MC; Caspell-Garcia C; Oertel W; Mollenhauer B; Amara A; Fernandez-Arcos A; Tolosa E; Simonet C; Hogl B; Videnovic A; Hutten SJ; Tanner C; Weintraub D; Burghardt E; Coffey C; Cho HR; Kieburtz K; Poston KL; Merchant K; Galasko D; Foroud T; Siderowf A; Marek K; Simuni T; Iranzo A
Ann Clin Transl Neurol; 2021 Jan; 8(1):201-212. PubMed ID: 33321002
[TBL] [Abstract][Full Text] [Related]
38. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.
Caminiti SP; Presotto L; Baroncini D; Garibotto V; Moresco RM; Gianolli L; Volonté MA; Antonini A; Perani D
Neuroimage Clin; 2017; 14():734-740. PubMed ID: 28409113
[TBL] [Abstract][Full Text] [Related]
39. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's disease.
Happe S; Tings T; Koch W; Welsch J; Helmschmied K; Baier PC; Meller J; Wuttke W; Paulus W; Tatsch K; Trenkwalder C
J Neural Transm (Vienna); 2007; 114(5):589-94. PubMed ID: 17187291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
